tiprankstipranks
Trending News
More News >
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO

BridgeBio Pharma (BBIO) Revenue

Compare
1,447 Followers

BridgeBio Pharma Revenue

BridgeBio Pharma had a revenue of 154.18M in the quarter ending Dec 31, 2025, with 27.74%. This bring the company's revenue in the last twelve months to 502.08M, Decreased 41.92%. In the fiscal year ending Dec 31, 2025, BridgeBio Pharma had annual revenue of 502.08M with 126.26% growth.
Revenue (ttm)
502.08M
Revenue Growth
62.46%
P/S Ratio
25.29
Revenue/Employee
$692,521
Employees
725
Market Cap
$12.70B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
502.08M280.18M+126.26%
Dec 31, 2024
221.90M212.60M+2,285.27%
Dec 31, 2023
9.30M-68.34M-88.02%
Dec 31, 2022
77.65M7.93M+11.38%
Dec 31, 2021
69.72M61.47M+745.14%
Dec 31, 2020
8.25M-32.31M-79.66%
Dec 31, 2019
40.56M+∞%
Dec 31, 2018
Dec 31, 2017